There is concern about the coming winter due to an increased number of COVID-19 infections. The virus can survive longer and will be more dangerous during this period. High travel activity during Thanksgiving and other holidays is likely to increase the number cases in multiple states. Thus, testing becomes more crucial. We believe that the fundamentally solid coronavirus stocks of Abbott Laboratory, Laboratory Corporation of America (NYSE 🙂 and Quest Diagnostics NYSE : are good bets. Read on.The steady recovery from COVID-19 came to a halt in the summer as new cases climbed due to the virus’ Delta variant. Since September through October, however, new cases started to decline as a result, thanks to various directives and mandates regarding vaccines and masks. The Centers for Disease Prevention and Control (CDC), however, reported that the number of cases rose 16.1% over the week prior, November 18. This raises concerns about a winter resurgence. Because the virus thrives in dry and cold conditions,

Additionally, people are returning to their homes for Thanksgiving and cases are rising across the nation. There have been more than 90,000.0 cases reported every day, plus more than 30 states reporting an increase in cases.

Last month, it was announced that unvaccinated travelers entering the United States would face stricter restrictions, requiring them to produce a document indication they’ve had a recent negative COVID-19 test. The mandate is expected to drive revenue for the coronavirus testing firms. In fact, between 2021 and 2027, the market for COVID-19 diagnostics is forecast to grow by 3.1%.

Continue reading on StockNews